Clinical
Research
Model
Partnering with Sponsors, CROs & Clinical Teams
At Nightingale Research, we work with global pharmaceutical companies, CROs, and medtech innovators to deliver high-quality community-based trials.
We know that successful trials rely on more than strong science. That’s why we build trusted referral networks, streamline workflows, and provide outstanding participant care from recruitment through follow-up.
Our sites are co-located with leading cardiology and specialist practices and supported by a wide network of referring GPs and allied health professionals.
We offer sponsors:
- Data-driven feasibility and early engagement planning
- Rapid patient identification through integrated clinical networks
- Ethics-ready documentation and site capability statements
- High retention through consistent, patient-focused follow-up
Our targeted recruitment strategy leverages:
- GP and specialist referrals
- Nurse-led screening and digital outreach
- Community engagement to create bespoke cohorts when needed
All studies adhere to Good Clinical Practice (GCP) and are supported by a robust quality assurance framework aligned with both national and international regulations.
Why Choose Nightingale?
Australia is globally recognised for its world-class research infrastructure, regulatory efficiency, and patient safety standards. At Nightingale, we leverage these strengths to conduct trials that are both timely and high quality.
What sets us apart:
- Fast study start-up: Most HREC reviews complete within 4–8 weeks through our independent ethics partners
- Flexible governance: We’re not bound by the restrictive processes typical of large public institutions
- Strategic locations: With sites in South Australia and Victoria, we access a broad cross-section of the population in stable, supportive environments
- Experienced workforce: Our team combines deep clinical expertise with operational excellence
